Bristlecone Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,488
| Closed | -$711K | – | 306 |
|
|
2025
Q1 | $711K | Sell |
10,488
-300
| -3% | -$18K | 0.06% | 169 |
|
|
2024
Q4 | $484K | Buy |
10,788
+448
| +4% | +$25.1K | 0.04% | 200 |
|
|
2024
Q3 | $650K | Buy |
10,340
+395
| +4% | +$23K | 0.05% | 166 |
|
|
2024
Q2 | $587K | Buy |
9,945
+828
| +9% | +$51.8K | 0.05% | 168 |
|
|
2024
Q1 | $727K | Sell |
9,117
-1,565
| -15% | -$120K | 0.06% | 157 |
|
|
2023
Q4 | $843K | Buy |
10,682
+3,939
| +58% | +$280K | 0.09% | 147 |
|
|
2023
Q3 | $471K | Hold |
6,743
| – | – | 0.05% | 177 |
|
|
2023
Q2 | $466K | Buy |
6,743
+1,538
| +30% | +$109K | 0.05% | 182 |
|
|
2023
Q1 | $387K | Hold |
5,205
| – | – | 0.04% | 192 |
|
|
2022
Q4 | $485K | Hold |
5,205
| – | – | 0.06% | 174 |
|
|
2022
Q3 | $496K | Sell |
5,205
-507
| -9% | -$50.2K | 0.06% | 166 |
|
|
2022
Q2 | $529K | Sell |
5,712
-561
| -9% | -$54.8K | 0.07% | 164 |
|
|
2022
Q1 | $635K | Sell |
6,273
-99
| -2% | -$10.4K | 0.08% | 141 |
|
|
2021
Q4 | $657K | Sell |
6,372
-475
| -7% | -$43.9K | 0.08% | 147 |
|
|
2021
Q3 | $581K | Sell |
6,847
-328
| -5% | -$27.5K | 0.08% | 143 |
|
|
2021
Q2 | $599K | Sell |
7,175
-100
| -1% | -$8.19K | 0.08% | 135 |
|
|
2021
Q1 | $547K | Sell |
7,275
-1,305
| -15% | -$95.1K | 0.08% | 138 |
|
|
2020
Q4 | $586K | Buy |
8,580
+345
| +4% | +$22.4K | 0.09% | 130 |
|
|
2020
Q3 | $481K | Buy |
8,235
+4,432
| +117% | +$276K | 0.09% | 128 |
|
|
2020
Q2 | $247K | Buy |
+3,803
| New | +$239K | 0.05% | 150 |
|
|
2020
Q1 | – | Sell |
-3,022
| Closed | -$225K | – | 164 |
|
|
2019
Q4 | $225K | Buy |
+3,022
| New | +$212K | 0.05% | 188 |
|
|
2019
Q2 | – | Sell |
-10,774
| Closed | -$581K | – | 178 |
|
|
2019
Q1 | $581K | Sell |
10,774
-910
| -8% | -$56.2K | 0.16% | 91 |
|
|
2018
Q4 | $766K | Sell |
11,684
-1,194
| -9% | -$89.1K | 0.23% | 90 |
|
|
2018
Q3 | $1.01M | Buy |
12,878
+4,192
| +48% | +$300K | 0.26% | 89 |
|
|
2018
Q2 | $559K | Sell |
8,686
-1,669
| -16% | -$110K | 0.19% | 96 |
|
|
2018
Q1 | $644K | Sell |
10,355
-2,593
| -20% | -$186K | 0.22% | 95 |
|
|
2017
Q4 | $939K | Sell |
12,948
-9,442
| -42% | -$686K | 0.3% | 86 |
|
|
2017
Q3 | $1.82M | Sell |
22,390
-1,055
| -4% | -$83.5K | 0.59% | 51 |
|
|
2017
Q2 | $1.89M | Sell |
23,445
-574
| -2% | -$45.3K | 0.64% | 50 |
|
|
2017
Q1 | $1.89M | Sell |
24,019
-1,434
| -6% | -$114K | 0.66% | 47 |
|
|
2016
Q4 | $2.01M | Sell |
25,453
-5,337
| -17% | -$432K | 0.72% | 43 |
|
|
2016
Q3 | $2.74M | Sell |
30,790
-4,380
| -12% | -$413K | 0.99% | 24 |
|
|
2016
Q2 | $3.38M | Buy |
35,170
+4,810
| +16% | +$479K | 1.25% | 18 |
|
|
2016
Q1 | $3.15M | Buy |
30,360
+3,130
| +11% | +$304K | 1.25% | 17 |
|
|
2015
Q4 | $2.66M | Buy |
+27,230
| New | +$2.67M | 1.12% | 18 |
|
Other funds holding CVS
Bristlecone Advisors's CVS Position: Q2 2025 in Review
Bristlecone Advisors sold out of CVS Health (CVS) in Q2 2025, closing a stake of 10,488 shares — an estimated $711K sold.
Bristlecone Advisors first reported a position in CVS in Q4 2015 and held it in 35 quarters. The position peaked at $3.38M in Q2 2016. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.
- Bristlecone Advisors reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
- Bristlecone Advisors sold 10,488 CVS Health shares in Q2 2025, an estimated $711K.
- Bristlecone Advisors first reported a position in CVS Health in Q4 2015 and held it in 35 quarters.
- Bristlecone Advisors's CVS Health position peaked at $3.38M in Q2 2016.
- 1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.
Based on Bristlecone Advisors's 13F filing for Q2 2025, filed 4 Aug 2025.